5-(4-Methoxy-benzoyl)-1,4-dimethyl-1,3-dihydro-imidazol-2-one | 77698-16-9

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: 5-(4-Methoxy-benzoyl)-1,4-dimethyl-1,3-dihydro-imidazol-2-one
• 英文别名: 5-(4-Methoxybenzoyl)-1,4-dimethyl-1,3-dihydro-2H-imidazol-2-one；4-(4-methoxybenzoyl)-3,5-dimethyl-1H-imidazol-2-one
• CAS: 77698-16-9
• 化学式: C₁₃H₁₄N₂O₃
• 分子量: 246.266
• InChiKey: VFRJMWYSNIKRAG-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.2
• 重原子数：
  18
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.23
• 拓扑面积：
  58.6
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  5-(4-Methoxy-benzoyl)-1,4-dimethyl-1,3-dihydro-imidazol-2-one 、 乙酸酐 生成 1,3-diacetyl-1,3-dihydro-4-(4-methoxybenzoyl)-5-methyl-2H-imidazol-2-one
  参考文献：
  名称：

  GRISAR, J. M.;SCHNEITTLER, R. A. =, DAGE, R. C.

  摘要：

  DOI：
• 作为产物：
  描述：

  1,3-dihydro-4-(4-methoxybenzoyl)-5-methyl-2H-1,3-imidazol-2-one 、 碘甲烷 生成 5-(4-Methoxy-benzoyl)-1,4-dimethyl-1,3-dihydro-imidazol-2-one
  参考文献：
  名称：

  GRISAR, J. M.;SCHNEITTLER, R. A. =, DAGE, R. C.

  摘要：

  DOI：

文献信息

• Novel 4-aroylimidazol-2-ones
  申请人：MERRELL DOW PHARMACEUTICALS INC.

  公开号：EP0058435A2

  公开（公告）日：1982-08-25

  Novel 4-aroylimidazol-2-ones of the following general structure which are useful as antihypertensives, cardiotonics and antithrombotics wherein Ar is 2-furyl, 2-thienyl or phenyl, the latter of which may optionally be substituted with one or two X groups; X is halogen, hydroxy, C1-4 alkyl, C1-4 alkoxy, methylenedioxy, C1-4 alkylthio, C1-4 alkylsulfoxide, C1-4 alkylsufone, CF3, -SO2N(R2)2, NR3R4, pyrrolidino, piperidino, morpholino, piperazino or N'-alkyl-piperazino, R is hydrogen, C1-4 alkyl, C1-4 alkylcarbonyl or benzyl; each of R1, R2, R3 and R4 are hydrogen or C1-4 alkyl; and the pharmaceutically acceptable salts thereof.

  具有以下一般结构的新型 4-芳基咪唑-2-酮，可用作抗高血压药、强心剂和抗血栓药 其中 Ar 是 2-呋喃基、2-噻吩基或苯基，后者可任选被一个或两个 X 基团取代；X 是卤素、羟基、C1-4 烷基、C1-4 烷氧基、亚甲基二氧基、C1-4 烷硫基、C1-4 烷基亚砜、C1-4 烷基砜、CF3、-SO2N(R2)2、NR3R4、吡咯烷基、哌啶基、吗啉基、哌嗪基或 N'- 烷基哌嗪基，R 是氢、C1-4 烷基、C1-4 烷基羰基或苄基；R1、R2、R3 和 R4 各为氢或 C1-4 烷基；及其药学上可接受的盐类。
• 4-Aroyl-1,3-dihydro-2H-imidazol-2-ones, a new class of cardiotonic agents
  作者：Richard A. Schnettler、Richard C. Dage、J. Martin Grisar

  DOI：10.1021/jm00354a017

  日期：1982.12

  A series of 4-aroyl-1,3-dihydro-2H-imidazol-2-ones was synthesized and evaluated for pharmacological activity in the anesthetized dog. Most members of this series produced dose-related increases in cardiac contractile force as well as relatively minor increases in heart rate and decreases in systemic arterial blood pressure that were not blocked by propranolol. In general, 4-methoxy or 4-methylthiobenzoyl substitution afforded compounds of greatest inotropic potency. 1,3-Dihydro-4-(4-methoxybenzoyl)-5-methyl-2H-imidazol-one (6) was shown to produce a dose-related positive inotropic effect and reverse the depressant effect of pentobarbital on cardiac pump function in the dog heart-lung preparation. The cardiotonic activity of this series may have important utility in the treatment of congestive heart failure. 1,3-Dihydro-4-[4-(methylthio)benzoyl]-5-methyl-2H-imidazol-2-one (17) was chosen for human studies and is currently undergoing clinical trials.
• GRISAR, J. M.;SCHNEITTLER, R. A. =, DAGE, R. C.
  作者：GRISAR, J. M.、SCHNEITTLER, R. A. =, DAGE, R. C.

  DOI：——

  日期：——